申请人:Stevens Francis G. Malcolm
公开号:US20060063816A1
公开(公告)日:2006-03-23
A compound of general structure I, wherein the compound is optionally in the form of an N-oxide or S-oxide
or prodrug form and/or pharmaceutically acceptable salt thereof wherein:
each of R
1
to R
9
is independently selected from hydrogen, hydroxyl, alkoxy, halo, mesyl, CX
3
(X=halo), —O(CH
2
)nNYZ—, substituted or unsubstituted lower alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted aryl or heteroaryl, and substituted or unsubstituted aralkyl or heteroaralkyl;
optionally R
6
and R
7
together form a dioxymethylene (—OCH
2
O—) unit and wherein n is 1 to 3 and
Y and Z are independently selected from any of the following: C
1
-C
6
straight chain, branched or cyclic substituted or unsubstituted alkyl group, Y and Z can be taken together to form a cyclic alkyl or hetereoalkyl group wherein in addition to N the hetereoalkyl group comprises a heteroatom selected from N, O or S.
通用结构I的化合物,其中该化合物可以是N-氧化物或S-氧化物或前药形式和/或其药用可接受盐形式,其中:R1至R9中的每一个独立地选择自氢、羟基、烷氧基、卤素、甲磺基、CX3(X=卤素)、—O(CH2)nNYZ—、取代或未取代的较低烷基、取代或未取代的杂烷基、取代或未取代的芳基或杂芳基,以及取代或未取代的芳基或杂芳基;可选地,R6和R7一起形成二氧亚甲基(—OCH2O—)单元,其中n为1至3,Y和Z分别选择自以下任一:C1-C6直链、支链或环状取代或未取代的烷基,Y和Z可以一起形成环状烷基或杂环烷基,其中除N外,杂环烷基还包括从N、O或S中选择的杂原子。